中华人民共和国疫苗管理法（征求意见稿）(67)
<P style="LINE-HEIGHT: 28pt; TEXT-INDENT: 32pt; MARGIN: 0cm 0cm 0pt; LAYOUT-GRID-MODE: char; mso-line-height-rule: exactly; mso-char-indent-count: 2.0; punctuation-wrap: simple; mso-layout-grid-align: none" class=a><FONT size=5><SPAN style="LAYOUT-GRID-MODE: line; FONT-FAMILY: 黑体; COLOR: black; mso-bidi-font-family: 黑体; mso-bidi-font-size: 16.0pt; mso-font-width: 0%" lang=EN-US><SPAN style="mso-list: Ignore">第七十三条</SPAN></SPAN><SPAN style="FONT-FAMILY: 黑体; COLOR: black; mso-bidi-font-weight: bold; mso-bidi-font-size: 16.0pt; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'">【检查结果运用</SPAN><SPAN style="FONT-FAMILY: 仿宋_GB2312; COLOR: black; mso-bidi-font-weight: bold; mso-bidi-font-size: 16.0pt; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'">】</FONT></SPAN><SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; mso-bidi-font-weight: bold; mso-fareast-font-family: 仿宋_GB2312; mso-bidi-font-size: 16.0pt" lang=EN-US><SPAN style="mso-spacerun: yes"> </SPAN></SPAN><SPAN style="FONT-FAMILY: 仿宋_GB2312; COLOR: black; mso-bidi-font-weight: bold; mso-bidi-font-size: 16.0pt; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'">疫苗存在质量安全风险或者企业质量管理存在安全隐患，未及时采取措施消除的，药品监督管理部门可以采取责任约谈、限期整改、责令召回等措施。严重违反药品质量管理规范的，药品监督管理部门应当责令暂停疫苗的生产、销售，立即查找原因并整改。未经药品监督管理部门检查符合要求的，不得恢复生产、销售。</SPAN><SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; mso-bidi-font-weight: bold; mso-fareast-font-family: 仿宋_GB2312; mso-bidi-font-size: 16.0pt" lang=EN-US><o:p></SPAN></FONT></FONT></P>
<P style="LINE-HEIGHT: 28pt; TEXT-INDENT: 32pt; MARGIN: 0cm 0cm 0pt; LAYOUT-GRID-MODE: char; mso-line-height-rule: exactly; mso-list: none; mso-char-indent-count: 2.0; punctuation-wrap: simple; mso-layout-grid-align: none" class=a><FONT size=5><SPAN style="FONT-FAMILY: 仿宋_GB2312; COLOR: black; mso-bidi-font-weight: bold; mso-bidi-font-size: 16.0pt; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'">将严重失信的疫苗上市许可持有人及其负责人列入</FONT></SPAN><SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; mso-bidi-font-weight: bold; mso-fareast-font-family: 仿宋_GB2312; mso-bidi-font-size: 16.0pt" lang=EN-US>“</SPAN><SPAN style="FONT-FAMILY: 仿宋_GB2312; COLOR: black; mso-bidi-font-weight: bold; mso-bidi-font-size: 16.0pt; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'">黑名单</FONT></SPAN><SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; mso-bidi-font-weight: bold; mso-fareast-font-family: 仿宋_GB2312; mso-bidi-font-size: 16.0pt" lang=EN-US>”</SPAN><SPAN style="FONT-FAMILY: 仿宋_GB2312; COLOR: black; mso-bidi-font-weight: bold; mso-bidi-font-size: 16.0pt; mso-ascii-font-family: 'Times New Roman'; mso-hansi-font-family: 'Times New Roman'">，实施跨部门联合惩戒。</SPAN><SPAN style="FONT-FAMILY: 'Times New Roman','serif'; COLOR: black; mso-bidi-font-weight: bold; mso-fareast-font-family: 仿宋_GB2312; mso-bidi-font-size: 16.0pt" lang=EN-US><o:p></SPAN></FONT></FONT></P>


总共97页  [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] 67 [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] 
上一页  下一页